.

Survey on Nurse Knowledge and Role in Management of Pediatric Thalassemia and Hematological Cancer Patients in Duhok Governorate

Dear Sir or Madam, please take a few minutes of your time to complete the following questionnaire.

Secured
1

What is your level of knowledge about thalassemia and hematological cancer management in pediatric patients?

Please select your level of knowledge.
2

How would you rate the current involvement of nurses in the management of pediatric thalassemia and hematological cancer patients?

Please rate from 1 to 10 where 1 is minimal involvement and 10 is extensive involvement.
3

What are the common challenges faced by nurses in managing pediatric thalassemia and hematological cancer patients in Duhok Governorate?

Please provide your answer in detail.
4

Are there specific training programs or workshops provided to nurses for enhancing their knowledge in managing pediatric thalassemia and hematological cancer patients?

Please select Yes or No.
5

How confident do you feel in providing emotional support to pediatric thalassemia and hematological cancer patients and their families?

Please rate your confidence level.
6

Do you think there is a need for increased resources and support for nurses managing pediatric thalassemia and hematological cancer patients in Duhok Governorate?

Please select Yes or No.
7

In your opinion, what additional training or resources could improve the care provided by nurses to pediatric thalassemia and hematological cancer patients?

Please provide your suggestions.
8

How well do you think nurses collaborate with other healthcare professionals in the management of pediatric thalassemia and hematological cancer patients?

Please rate the level of collaboration.
9

Have you encountered any ethical dilemmas in the care of pediatric thalassemia and hematological cancer patients? If yes, please describe.

Please provide details of any ethical dilemmas faced.
10

What improvements do you think can be made to enhance the support system for nurses managing pediatric thalassemia and hematological cancer patients?

Please provide your suggestions.